Use of covered self-expandable stents for benign colorectal disorders in children

Bettina Lange1, Moritz Sold2, Georg Kähler2

  • 1Medical Faculty Mannheim, Heidelberg University, University Medical Center Mannheim, Department of Pediatric Surgery, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany.

Insights

Covered self-expandable stents offer a new treatment option for benign colorectal conditions in children, including strictures and leaks. While complications are common, these stents can provide temporary or permanent improvement, sometimes avoiding surgery.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Medical Devices

Background:

  • Benign colorectal disorders in children are challenging to treat.
  • Experience with covered self-expandable stents in pediatric colorectal conditions is limited.

Purpose of the Study:

  • To evaluate the efficacy and safety of covered self-expandable stents for benign colorectal disorders in pediatric patients.
  • To assess stent-related complications and outcomes in this population.

Main Methods:

  • Retrospective study of five pediatric patients (median age 5 years) treated with covered self-expandable plastic stents (SEPSs) or self-expandable metal stents (SEMSs).
  • Indications included anastomotic strictures with or without enterocutaneous fistulas and anastomotic leaks with enterocutaneous fistulas.
  • Underlying conditions were Hirschsprung's disease or total colonic aganglionosis.

Main Results:

  • Median stent placement duration was 23 days, with up to five stents used per patient.
  • Two patients achieved successful treatment without further intervention.
  • Three patients required definitive surgery due to incomplete improvement; all cases experienced stent-related problems, including perforation, dislocation, and obstruction.

Conclusions:

  • Covered self-expandable stents represent a valuable addition to the treatment options for pediatric benign colorectal disorders.
  • Stents can be used as an emergency measure or as an adjunct to other endoscopic treatments.
  • Despite frequent complications, stents offer potential for temporary or definitive improvement in pediatric patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
833
Endoscopic Procedures II: Colonoscopy01:25

Endoscopic Procedures II: Colonoscopy

The colon, or large intestine, is the final segment of the digestive system. Its primary functions include absorbing water and vitamins produced by gut bacteria and transforming waste from liquid to solid to form stool. In adults, the large intestine is approximately 5 feet long and consists of four main sections:
1.1K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
605
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.2K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
877